Carregant...

Aggregation Kinetics for IgG1-Based Monoclonal Antibody Therapeutics

Monoclonal antibodies (mAbs) as a class of therapeutic molecules are finding an increasing demand in the biotechnology industry for the treatment of diseases like cancer and multiple sclerosis. A key challenge associated to successful commercialization of mAbs is that from the various physical and c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AAPS J
Autors principals: Singla, A., Bansal, R., Joshi, Varsha, Rathore, Anurag S.
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5256606/
https://ncbi.nlm.nih.gov/pubmed/26902302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-016-9887-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!